Skip links

Are you attending BAUS 2019?

We are counting down to BAUS 2019 in Glasgow next week.

Will you be in Glasgow this year? If so, visit us on Stand 445 between 24-26 June to find out more about the EMDA® Bladder Cancer Treatment.

EMDA® has been proven to significantly prolong the disease-free interval and reduce the risk of recurrence in high and intermediate-risk patients with NMIBO (non-muscle invasive bladder cancer).

Following an interventional procedure overview of the EMDA® (Electromotive Drug Administration) treatment in June 2018, NICE issued updated guidance for clinicians in England and Wales on 30 January 2019 and called for EMDA® to be used in research programmes as a treatment for bladder cancer.

There are currently studies underway at several Urology clinics including Guy’s & St Thomas’ NHS Foundation Trust in London and Salisbury District Hospital. Contact us to find a clinic near you. 

For more information on EMDA® or to arrange a meeting at BAUS 2019, please contact Robin Luper on +44 (0)1234-888955 or by email via


Further information

EMDA® Treatment

Guy’s & St Thomas’ NHS Foundation Trust

Salisbury District Hospital


NHS England Bladder Cancer